Cervical Neuroendocrine Carcinoma
Associated Genetic Biomarkers
There is 1 clinical trial for cervical neuroendocrine carcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains cervical neuroendocrine carcinoma as an inclusion criterion, 1 is phase 2 (1 open).
Bintrafusp alfa is the most common intervention in cervical neuroendocrine carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.